Mannan-decorated thiolated Eudragit microspheres for targeting antigen presenting cells via nasal vaccination

European Journal of Pharmaceutical Sciences

Volumn 80, Issue , 2015, Pages 16-25

  Li, Hui Shan ^a   Singh, Bijay ^a   Park, Tae Eun ^a   Hong, Zhong Shan ^b   Kang, Sang Kee ^a   Cho, Chong Su ^a   Choi, Yun Jaie ^a,b  

^a Seoul National University   (South Korea)

^b TIANJIN AGRICULTURAL UNIVERSITY   (China)

Author keywords

Adjuvant; Antigen presenting cells (APCs); Mannan; Mannose receptor targeting; Mucoadhesive microspheres; Nasal vaccine

Indexed keywords

EUDRAGIT; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; MANNAN; MANNOSE RECEPTOR; MICROSPHERE; OVALBUMIN; THIOLATED EUDRAGIT; UNCLASSIFIED DRUG; IMMUNOGLOBULIN G; LECTIN RECEPTOR; MANNAN RECEPTOR; METHYLMETHACRYLATE-METHACRYLIC ACID COPOLYMER; POLYMETHACRYLIC ACID DERIVATIVE; SECRETORY IMMUNOGLOBULIN; VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG TARGETING; ENDOCYTOSIS; FEMALE; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; VACCINATION; ANIMAL; BAGG ALBINO MOUSE; BLOOD; CELL LINE; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIGEN-PRESENTING CELLS; CELL LINE; FEMALE; IMMUNOGLOBULIN A, SECRETORY; IMMUNOGLOBULIN G; MANNANS; MICE; MICE, INBRED BALB C; MICROSPHERES; POLYMETHACRYLIC ACIDS; RECEPTORS, MITOGEN; VACCINES;

EID: 84943179217     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2015.09.014     Document Type: Article

References (35)

1. M. Amidi, S.G. Romeijn, G. Borchard, H.E. Junginger, W.E. Hennink, and W. Jiskoot Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system J. Control. Release 111 2006 107 116
2. A. Bernkop-Schnürch, A.E. Clausen, and M. Hnatyszyn Thiolated polymers: synthesis and in vitro evaluation of polymer-cysteamine conjugates Int. J. Pharm. 226 2001 185 194
3. A. Bernkop-Schnürch, A.H. Krauland, V.M. Leitner, and T. Palmberger Thiomers: potential excipients for non-invasive peptide delivery systems Eur. J. Pharm. Biopharm. 58 2004 253 263
4. J.A. Champion, A. Walker, and S. Mitragotri Role of particle size in phagocytosis of polymeric microspheres Pharm. Res. 25 2008 1815 1821
5. Z. Cui, and R.J. Mumper Topical immunization using nanoengineered genetic vaccines J. Control. Release 81 2002 173 184
6. C. Czerkinsky, and J. Holmgren Mucosal delivery routes for optimal immunization: targeting immunity to the right tissues, mucosal vaccines 2012 Springer 1 18
7. M.A. Dobrovolskaia, and S.E. McNeil Immunological properties of engineered nanomaterials Nat. Nanotechnol. 2 2007 469 478
8. C. Foged, A. Sundblad, and L. Hovgaard Targeting vaccines to dendritic cells Pharm. Res. 19 2002 229 238
9. X.-G. Gu, M. Schmitt, A. Hiasa, Y. Nagata, H. Ikeda, Y. Sasaki, K. Akiyoshi, J. Sunamoto, H. Nakamura, and K. Kuribayashi A novel hydrophobized polysaccharide/oncoprotein complex vaccine induces in vitro and in vivo cellular and humoral immune responses against HER2-expressing murine sarcomas Cancer Res. 58 1998 3385 3390
10. N. Hagenaars, M. Mania, P. de Jong, I. Que, R. Nieuwland, B. Slütter, H. Glansbeek, J. Heldens, H. van den Bosch, and C. Löwik Role of trimethylated chitosan (TMC) in nasal residence time, local distribution and toxicity of an intranasal influenza vaccine J. Control. Release 144 2010 17 24
11. A. Henning, M. Schneider, N. Nafee, L. Muijs, E. Rytting, X. Wang, T. Kissel, D. Grafahrend, D. Klee, and C.-M. Lehr Influence of particle size and material properties on mucociliary clearance from the airways J. Aerosol Med. Pulm. Drug Deliv. 23 2010 233 241
12. J. Holmgren, and C. Czerkinsky Mucosal immunity and vaccines Nat. Med. 11 2005 S45 S53
13. L. Illum Nasal drug delivery - possibilities, problems and solutions J. Control. Release 87 2003 187 198
14. M.A. Islam, H.-L. Jiang, J.-S. Quan, R.B. Arote, M.-L. Kang, H.-S. Yoo, C.-H. Yun, Y.-J. Choi, and C.-S. Cho Mucoadhesive and pH-sensitive thiolated Eudragit microspheres for oral delivery of Pasteurella multocida antigens containing dermonecrotoxin J. Nanosci. Nanotechnol. 11 2011 4174 4181
15. K. Jaganathan, and S.P. Vyas Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally Vaccine 24 2006 4201 4211
16. H.-L. Jiang, M.L. Kang, J.-S. Quan, S.G. Kang, T. Akaike, H.S. Yoo, and C.-S. Cho The potential of mannosylated chitosan microspheres to target macrophage mannose receptors in an adjuvant-delivery system for intranasal immunization Biomaterials 29 2008 1931 1939
17. M.L. Kang, H.-L. Jiang, S.G. Kang, D.D. Guo, D.Y. Lee, C.-S. Cho, and H.S. Yoo Pluronic® F127 enhances the effect as an adjuvant of chitosan microspheres in the intranasal delivery of bordetella bronchiseptica antigens containing dermonecrotoxin Vaccine 25 2007 4602 4610
18. T. Keler, V. Ramakrishna, and M.W. Fanger Mannose receptor-targeted vaccines Expert. Opin. Biol. Ther. 4 2004 1953 1962
19. V.V. Khutoryanskiy Advances in mucoadhesion and mucoadhesive polymers Macromol. Biosci. 11 2011 748 764
20. W.-J. Lee, S. Cha, M. Shin, M.A. Islam, C.-s. Cho, and H.S. Yoo Induction of Th1 polarized immune responses by thiolated eudragit-coated F4 and F18 fimbriae of enterotoxigenic Escherichia coli Eur. J. Pharm. Biopharm. 79 2011 226 231
21. W.-J. Lee, S. Cha, M. Shin, M. Jung, M.A. Islam, C.-s. Cho, and H.S. Yoo Efficacy of thiolated eudragit microspheres as an oral vaccine delivery system to induce mucosal immunity against enterotoxigenic Escherichia coli in mice Eur. J. Pharm. Biopharm. 81 2012 43 48
22. N. Lycke Recent progress in mucosal vaccine development: potential and limitations Nat. Rev. Immunol. 12 2012 592 605
23. D. Mizuno, M. Ide-Kurihara, T. Ichinomiya, I. Kubo, and H. Kido Modified pulmonary surfactant is a potent adjuvant that stimulates the mucosal IgA production in response to the influenza virus antigen J. Immunol. 176 2006 1122 1130
24. V. Neuhaus, J.A. Chichester, T. Ebensen, K. Schwarz, C.E. Hartman, Y. Shoji, C.A. Guzmán, V. Yusibov, K. Sewald, and A. Braun A new adjuvanted nanoparticle-based H1N1 influenza vaccine induced antigen-specific local mucosal and systemic immune responses after administration into the lung Vaccine 32 2014 3216 3222
25. C.R. Oechslein, G. Fricker, and T. Kissel Nasal delivery of octreotide: Absorption enhancement by particulate carrier systems Int. J. Pharm. 139 1996 25 32
26. J.-S. Quan, H.-L. Jiang, E.-M. Kim, H.-J. Jeong, Y.-J. Choi, D.-D. Guo, M.-K. Yoo, H.-G. Lee, and C.-S. Cho pH-sensitive and mucoadhesive thiolated Eudragit-coated chitosan microspheres Int. J. Pharm. 359 2008 205 210
27. T.R.R.S. Rahamatullah Shaikh, M.J. Garland, A.D. Woolfson, and R.F. Donnelly Mucoadhesive drug delivery systems J. Pharm. Bioallied Sci. 3 2011 89
28. K.B. Renegar, P.A. Small, L.G. Boykins, and P.F. Wright Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract J. Immunol. 173 2004 1978 1986
29. S. Sasaki, J. Fukushima, H. Arai, K.I. Kusakabe, K. Hamajima, N. Ishii, F. Hirahara, K. Okuda, S. Kawamoto, and J.M. Ruysschaert Human immunodeficiency virus type-1-specific immune responses induced by DNA vaccination are greatly enhanced by mannan-coated diC14-amidine Eur. J. Immunol. 27 1997 3121 3129
30. P.J. Tacken, I.J.M. de Vries, R. Torensma, and C.G. Figdor Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting Nat. Rev. Immunol. 7 2007 790 802
31. M.E. Taylor, J. Conary, M. Lennartz, P.D. Stahl, and K. Drickamer Primary structure of the mannose receptor contains multiple motifs resembling carbohydrate-recognition domains J. Biol. Chem. 265 1990 12156 12162
32. P.R. Taylor, L. Martinez-Pomares, M. Stacey, H.-H. Lin, G.D. Brown, and S. Gordon Macrophage receptors and immune recognition Annu. Rev. Immunol. 23 2005 901 944
33. M. Vajdy, and D.T. O'Hagan Microparticles for intranasal immunization Adv. Drug Deliv. Rev. 51 2001 127 141
34. H.A. Vaughan, D.W. Ho, V. Karanikas, M.S. Sandrin, I.F. McKenzie, and G.A. Pietersz The immune response of mice and cynomolgus monkeys to macaque mucin 1-mannan Vaccine 18 2000 3297 3309
35. E. Vinogradov, B. Petersen, and K. Bock Structural analysis of the intact polysaccharide mannan from Saccharomyces cerevisiae yeast using 1 H and 13C NMR spectroscopy at 750 MHz Carbohydr. Res. 307 1998 177 184